Literature DB >> 6498586

Anaesthetic management with morphine in phaeochromocytoma.

M Hamaji, N Oka, C Tashiro, T Seki, M Miyata, Y Kawashima.   

Abstract

Morphine was used as the principal anaesthetic agent for five patients undergoing resection of phaeochromocytoma, and changes in plasma catecholamines were monitored. Phenoxygenzamine (0.5 mg X kg-1 X day-1) was orally given one week before operation. After premedication with hyoscine (0.4 mg) and diazepam (20 mg) of meperidine (50 mg), anaesthesia was induced with an infusion of morphine (1 mg X kg-1) over 30 min and maintained with diazepam, nitrous oxide and oxygen. Pancuronium was used as the muscle relaxant. In three of the five patients, blood pressure transiently rose (ranging from 15 to 60 mg) following orotracheal intubation, but vasodilators were not required. In two of the three, plasma norepinephrine increases were 1.1 and 1.3 ng X ml-1. In the other two patients, whose blood pressure was stable, the change in plasma norepinephrine was 0.1 and 0.7 ng X ml-1. After reaching a peak at the time of ligation of drainage vein from the tumour, plasma catecholamines rapidly decreased to the preoperative levels, but the blood pressure was well maintained in all cases. Ventricular arrhythmias did not occur despite the increased levels of endogenous catecholamines. These findings suggest that morphine can be used as an alternative anaesthetic agent during operation for phaeochromocytoma and that exaggerated pressor responses to morphine (when given slowly) seem not to occur in phaeochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498586     DOI: 10.1007/bf03008767

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  29 in total

1.  ELEVATION OF PLASMA HISTAMINE LEVELS IN THE DOG FOLLOWING ADMINISTRATION OF MUSCLE RELAXANTS, OPIATES AND MACROMOLECULAR POLYMERS.

Authors:  W L THOMPSON; R P WALTON
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

2.  Proceedings: Circulatory effects of morphine.

Authors:  I O Samuel; J W Dundee
Journal:  Br J Anaesth       Date:  1975-09       Impact factor: 9.166

3.  Diamorphine-induced attack of paroxysmal hypertension in phaeochromocytoma.

Authors:  N C Chaturvedi; M J Walsh; D M Boyle; J M Barber
Journal:  Br Med J       Date:  1974-06-08

4.  The use of neuroleptanalgesia during surgery for phaeochromocytoma. Reports of two cases.

Authors:  A D Clarke; M A Tobias; P D Challen
Journal:  Br J Anaesth       Date:  1972-10       Impact factor: 9.166

5.  Studies on the morphine-induced release of catecholamines from the adrenal glands in the dog.

Authors:  S O Kayaalp; S Kaymakçalan
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-03

Review 6.  Anaesthetic management of phaeochromocytoma.

Authors:  V Pratilas; M G Pratila
Journal:  Can Anaesth Soc J       Date:  1979-07

7.  Use of isoflurane during resection of pheochromocytoma.

Authors:  M Suzukawa; I A Michaels; J Ruzbarsky; C J Kopriva; L M Kitahata
Journal:  Anesth Analg       Date:  1983-01       Impact factor: 5.108

8.  Effects of morphine on ventricular function and myocardial contractile force.

Authors:  J S Vasko; R P Henney; R K Brawley; H N Oldham; A G Morrow
Journal:  Am J Physiol       Date:  1966-02

9.  Pheochromocytoma: current status and changing trends.

Authors:  J A van Heerden; S G Sheps; B Hamberger; P F Sheedy; J G Poston; W H ReMine
Journal:  Surgery       Date:  1982-04       Impact factor: 3.982

10.  Enflurane anesthesia for surgical removal of pheochromocytoma.

Authors:  G F Janeczko; A D Ivankovich; S N Glisson; H J Heyman; A A El-Etr; R F Albrecht
Journal:  Anesth Analg       Date:  1977 Jan-Feb       Impact factor: 5.108

View more
  2 in total

1.  Midazolam-sufentanil anaesthesia for phaeochromocytoma resection.

Authors:  J D Shapiro; A el-Ganzouri; P F White; A D Ivankovich
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

Review 2.  Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.